TITLE

Arthrocare gets FDA market clearance for spinal surgery system

PUB. DATE
February 2000
SOURCE
Biotech Equipment Update;2000, p2
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on Arthrocare Corp.'s receipt of 510(k) clearance from the United States Food and Drug Administration to market the company's Coblation-based soft-tissue surgery system for spinal surgery. Plans for an immediate launch in the US; Establishment of the distribution channel for the special surgery product; Features of the product; Contact information.
ACCESSION #
2714364

 

Related Articles

  • ArthroCare's WoundWand wins CE mark.  // Biomedical Business & Technology;Jan2011, Vol. 34 Issue 1, p19 

    This article announces the CE mark received by ArthroCare for its WoundWand debridement device.

  • ARTHROCARE REPORTS 2ND QTR 2010 TOTAL REVENUE OF $88.8 MIL.  // Biotech Financial Reports;Sep2010, Vol. 17 Issue 9, p6 

    The article reports on the total revenue of 88.8 million dollars of Arthrocare Corp., developer of state-of-the-art, minimally invasive surgical products, during the second quarter of 2010. It indicates that the company's product margin has reached 65.9 percent and its operating income it worth...

  • FDA clears novel ENT device to aid surgeons in operations.  // Hudson Valley Business Journal;03/13/2000, Vol. 11 Issue 2, p11 

    Reports that Sunnyvale, California-based ArthroCare Corp. has received United States Food and Drug Administration clearance to market its EVac disposable surgical device for ear, nose and throat surgery. Features and capabilities of the device.

  • ArthroCare Announces 3rd Qtr 2011 Financial Results Press Release and Conference Call Dates.  // Biomedical Market Newsletter;10/31/2011, Vol. 21, p222 

    The article focuses on the plan of Texas-based ArthroCare Corp. to publish a press release for the third quarter 2011 financial results after the market closes on November 2, 2011. The company also plans to host a conference call on November 3 to review the financial results. It provides an...

  • INCOME (LOSS) FROM OPERATIONS.  // Biotech Financial Reports;Sep2010, Vol. 17 Issue 9, p7 

    The article reports on the income loss experienced by ArthroCare Corp., developer of state-of-the-art and minimally invasive surgical products, from its business operations during the second quarter of 2010. The company's sales and marketing and general and administrative expenses have decreased...

  • BALANCE SHEET AND CASH FLOWS.  // Biotech Financial Reports;Sep2010, Vol. 17 Issue 9, p7 

    The article reports on the performance of the balance sheet and cash flows of ArthroCare Corp., developer of state-of-the-art and minimally invasive surgical products, during the second quarter of 2010. The company has experienced an increase in cash flows by 25.8 million dollars to 83.2 million...

  • ArthroCare in $75M share buyback; Credentia in $10.2M debt financing.  // Medical Device Daily;2/28/2008, Vol. 12 Issue 40, p4 

    The article reports that the board of ArthroCare, a developer of minimally invasive surgical products, has approved the additional repurchase of up to $75 million of its outstanding common stock. According to the company, they fully utilized its prior share repurchase authorization that was...

  • ArthroCare Reports 1st Qtr 2012 Financial Results.  // Biomedical Market Newsletter;5/7/2012, Vol. 21, p1 

    The article informs that ArthroCare Corp. has released its financial results for the 1st quarter of 2012. It further informs that the company will be hosting a conference call on May 3, 2012 to discuss the results with the financial community. It mentions that the company is working on improving...

  • ArthroCare Receives FDA Clearance for Spartan 6.5 Needled Suture Implant.  // Biomedical Market Newsletter;6/9/2011, p482 

    The article reports on the announcement of ArthroCare® Corp. that the U.S. Food and Drug Administration (FDA) has given the clearance for its Spartan™ 6.5 Needled Anchor. It states that the anchor could be utilized in line with the suture passing technology of the company like the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics